Heterocyclic chalcone analogues as potential anticancer agents
- PMID: 22721390
Heterocyclic chalcone analogues as potential anticancer agents
Abstract
Chalcones, aromatic ketones and enones acting as the precursor for flavonoids such as Quercetin, are known for their anticancer effects. Although, parent chalcones consist of two aromatic rings joined by a three-carbon α,β-unsaturated carbonyl system, various synthetic compounds possessing heterocyclic rings like pyrazole, indole etc. are well known and proved to be effective anticancer agents. In addition to their use as anticancer agents in cancer cell lines, heterocyclic analogues are reported to be effective even against resistant cell lines. In this connection, we hereby highlight the potential of various heterocyclic chalcone analogues as anticancer agents with a brief summary about therapeutic potential of chalcones, mechanism of anticancer action of various chalcone analogues, and current and future prospects related to the chalcones-derived anticancer research. Furthermore, some key points regarding chalcone analogues have been reviewed by analyzing their medicinal properties.
Similar articles
-
Synthesis and biological evaluation of a novel series of chalcones incorporated pyrazole moiety as anticancer and antimicrobial agents.Appl Biochem Biotechnol. 2012 Nov;168(5):1153-62. doi: 10.1007/s12010-012-9848-8. Epub 2012 Sep 5. Appl Biochem Biotechnol. 2012. PMID: 22948604
-
Inhibitors and promoters of tubulin polymerization: synthesis and biological evaluation of chalcones and related dienones as potential anticancer agents.Bioorg Med Chem. 2011 Apr 15;19(8):2659-65. doi: 10.1016/j.bmc.2011.03.005. Epub 2011 Mar 10. Bioorg Med Chem. 2011. PMID: 21459004
-
Design, Synthesis, and Evaluation of (2-(Pyridinyl)methylene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity.Med Chem. 2018;14(4):333-343. doi: 10.2174/1573406413666171020121244. Med Chem. 2018. PMID: 29065840
-
Anticancer Active Heterocyclic Chalcones: Recent Developments.Anticancer Agents Med Chem. 2021;21(5):558-566. doi: 10.2174/1871520620666200705215722. Anticancer Agents Med Chem. 2021. PMID: 32628595 Review.
-
Perspectives of medicinally privileged chalcone based metal coordination compounds for biomedical applications.Eur J Med Chem. 2019 Jul 15;174:142-158. doi: 10.1016/j.ejmech.2019.04.032. Epub 2019 Apr 16. Eur J Med Chem. 2019. PMID: 31035237 Review.
Cited by
-
The effect of novel nitrogen-based chalcone analogs on colorectal cancer cells: Insight into the molecular pathways.Heliyon. 2024 Feb 27;10(5):e27002. doi: 10.1016/j.heliyon.2024.e27002. eCollection 2024 Mar 15. Heliyon. 2024. PMID: 38463818 Free PMC article.
-
Anticancer Activity of Roburic Acid: In Vitro and In Silico Investigation.Int J Mol Sci. 2025 Jul 3;26(13):6420. doi: 10.3390/ijms26136420. Int J Mol Sci. 2025. PMID: 40650205 Free PMC article.
-
Synthetic chalcones with potent antioxidant ability on H₂O₂-induced apoptosis in PC12 cells.Int J Mol Sci. 2014 Oct 14;15(10):18525-39. doi: 10.3390/ijms151018525. Int J Mol Sci. 2014. PMID: 25318055 Free PMC article.
-
Synthesis, molecular docking, assessment of biological and anti-diabetic properties of benzalacetophenone derivatives.Sci Rep. 2025 Apr 23;15(1):14159. doi: 10.1038/s41598-025-96610-6. Sci Rep. 2025. PMID: 40269055 Free PMC article.
-
Pharmacological potential of natural chalcones: a recent studies and future perspective.Front Pharmacol. 2025 Jun 17;16:1570385. doi: 10.3389/fphar.2025.1570385. eCollection 2025. Front Pharmacol. 2025. PMID: 40599794 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources